Skip to content

LyondellBasell Industries N.V. LYB I&D — Goodwill impairments

Other segment segments

Technology
$0

Similar metrics at other companies

General Mills logo
GISInternational — Goodwill impairment
$0
Hain Celestial Group logo
HAINInternational — Goodwill Impairment
$193.84M+989%
Lakeland Industries logo
LAKEGoodwill Impairments
$651K-75.3%
Harmonic logo
HLITGoodwill Impairment
$14.38M
Bausch Health Companies logo
BHCGoodwill impairments
$1.43B
SolarEdge Technologies logo
SEDGGoodwill And Intangible Asset Impairment
$0+100%

Other financials

Income statement

See full
Revenue$7.2B-6.3%
Gross profit$701.0M+27.7%
Operating income$239.0M+110%
Net income$125.0M-29.4%
EPS (diluted)$0.38-29.6%

Balance sheet

See full
Cash & equivalents$2.6B+41.1%
Total debt$12.8B+5.1%
Total equity$10.0B-17.8%
Total assets$34.0B-3.5%

Cash flow

See full
Operating cash flow-$269.0M+53.5%
CapEx$269.0M-44.3%
Free cash flow-$538.0M+49.3%

Valuation

See full
Market cap$16.99B-8.2%
Enterprise value$27.14B-8.2%
P/S0.6×0.0×

Profitability

See full
Gross margin9.2%-3.3pp
Operating margin-1%
Net margin-2.7%
FCF margin3.1%-1.6pp

Returns & leverage

See full
Return on equity-7.1%
Debt / equity1.3×+0.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by LyondellBasell Industries N.V. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: LyondellBasell Industries N.V.’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about LyondellBasell Industries N.V.'s i&d — goodwill impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LyondellBasell Industries N.V.'s I&D — goodwill impairments?
LyondellBasell Industries N.V. (LYB) reported I&D — goodwill impairments of $0 in Q4 2025.
What does I&D — goodwill impairments mean?
A non-cash charge recorded when the carrying amount of goodwill within the segment exceeds its implied fair value. This indicates that the expected future economic benefits of past acquisitions have declined. It serves as a critical indicator of the segment's long-term competitive health and asset valuation accuracy.